Control Intervention1: NIL: NIL, This is an observational study
Sponsors
Department of Biotechnology Systems Medicine Cluster SyMeC Kolkata, Tata Trusts, Zifo RnD Solutions
Conditions
Health Condition 1: D728- Other specified disorders of whiteblood cellsHealth Condition 1: E112- Type 2 diabetes mellitus with kidney complicationsHealth Condition 1: null- Patients with Gingivo buccal-Oral squamous cell carcinoma
Unknown Phase
Immune micro-environment and immune genomics of head and neck cancer
Active, not recruitingCTRI/2018/07/014757
Target: 100Updated: 2022-10-17
Acute Myeloid Leukemia Multimodal Genomics
RecruitingCTRI/2019/04/018782
Target: 50Updated: 2021-11-24
Whole exome sequencing of patients having comorbidities associated with type 2 diabetes.
RecruitingCTRI/2020/01/022821
Target: 20000Updated: 2021-11-24